NASDAQ:MBOT

Microbot Medical Q3 2026 Earnings Results & Report

Microbot Medical logo
$0.64 -0.33 (-34.16%)
Closing price 11/16/2026 04:00 PM Eastern
Extended Trading
$0.65 +0.01 (+1.18%)
As of 11/16/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Microbot Medical missed analyst earnings expectations but beat on revenue in its Q3 2026 results, released November 13, 2026. The company reported EPS of -$0.09 versus the -$0.0825 consensus estimate, while revenue of $72 thousand topped the $8 thousand estimate by $64 thousand.

Earnings Announcement Details

Quarter
Q3 2026
Time
After Market Closes
Conference Call
7:00 AM ET

Microbot Medical EPS Results

Actual EPS
-$0.09
Consensus EPS
-$0.0825
Beat/Miss
Missed by -$0.0075
One Year Ago EPS
N/A
EPS Beat Rate
3 of last 8 quarters

Microbot Medical Revenue Results

Actual Revenue
$72 thousand
Expected Revenue
$8 thousand
Beat/Miss
Beat by +$64.00 thousand
YoY Revenue Growth
N/A

Earnings Documents

Microbot Medical Q3 2026 Earnings FAQ

Microbot Medical (NASDAQ:MBOT) reported earnings of -$0.09 per share for Q3 2026, missing the consensus estimate of -$0.0825. The report was announced on Friday, November 13, 2026.

Microbot Medical reported revenue of $72 thousand for Q3 2026, against a consensus estimate of $8 thousand.

Microbot Medical Earnings Headlines

Top Trader Reveals Stunning Black Friday Deal
Others paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Trading's Thomas Wood calls it one of the firm's most powerful proprietary trading indicators, and says the company has never run a deal like this before. There are no strings attached, just a steep Black Friday discount on a tool built for traders.tc pixel
Microbot Medical (MBOT) Expected to Post Earnings on Wednesday
Microbot Medical Adds Canadian Patent to IP Portfolio
See More Microbot Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Microbot Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Microbot Medical and other key companies, straight to your email.

About Microbot Medical

Microbot Medical (NASDAQ:MBOT) is a medical-device company developing robotic technologies for endovascular procedures. Its work focuses on tools intended to help physicians navigate blood vessels and perform minimally invasive interventions.

The company’s lead platform, LIBERTY, is a remotely operated robotic system designed for endovascular procedures. The system is intended to work with guidewires and catheters and to support physicians in controlling these devices during treatment.

Microbot Medical is based in the United States and has roots in Israel. Its activities center on developing and advancing medical technologies rather than a broad portfolio of established commercial products.

View Microbot Medical Profile